Developer docs
API playgroundTry for free, no card

Search company profiles

IDIBAPS

Full company profile

uuid000bdgc

Namestring
IDIBAPS
Legal namestring
IDIBAPS
Websiteurl
idibaps.org
Company typeenum
Private
Founded yearint
1996
Descriptiontext

IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer) is a Barcelona-based biomedical research institute founded in 1996 that translates laboratory science into clinical practice. It organizes its work around 101 research groups and seven core scientific platforms: a Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. The institute serves physicians, clinical researchers, and biomedical scientists, and supervises approximately 100 doctoral theses per year alongside roughly 25 scientific seminars annually.

The institute is structured as a multi-institutional public research consortium rather than a commercial entity. It is anchored by Hospital Clínic de Barcelona (clinical environment) and Universitat de Barcelona (academic affiliation), with institutional support from Generalitat de Catalunya and membership in the CERCA network of Catalan research centers. Funding flows from competitive grants awarded by bodies such as Instituto de Salud Carlos III, the European Union framework programmes, and philanthropic organizations including the Asociación Española Contra el Cáncer, supplemented by block institutional funding. Pricing is not applicable because IDIBAPS does not commercialize products or services; outputs are scientific publications (over 1,200 original articles per year), trained researchers, clinical-trial support, and knowledge and technology transfer back to Hospital Clínic and the broader research ecosystem.

The operating footprint is concentrated at a single headquarters location at Centre Esther Koplowitz in Barcelona (C/Rosselló 149-153), where platforms and research groups are co-located with the affiliated tertiary hospital. Activity indicators — 930+ active competitive projects, recurring international collaborations, and a published 2025-2028 Strategic Plan — evidence sustained operations and incremental capability build-out (e.g., recent onboarding of high-depth multiomics instrumentation such as MACSima™). The renewed European HR Excellence in Research seal (July 2026) reinforces the institute's role as a publicly funded, translational research entity rather than a productized or revenue-generating business.

Short descriptiontext

IDIBAPS is a Barcelona-based biomedical research institute that runs 101 research groups across seven scientific platforms (biobank, genomics, MRI, cytometry, biostatistics, clinical trials, and scientific computing) to translate laboratory science into patient care, funded primarily through competitive public grants.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biomedical research services, translational medicine, clinical trials support, scientific core platforms, clinical simulation training
Industry3 codes
1Biomedical Sciences & Medical Research Institutes (University-Based)
CodeEDAHAGAIPrimaryYes
2Academic Medical Centers & Teaching Hospitals (University-Affiliated)
CodeEDAHAGAAPrimaryNo
3Public Research Universities with Academic Medical Centers (AMCs)
CodeEDAHAAACPrimaryNo
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Biomedical Research Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Competitive Research Funding
TypeManaged Services
Description

IDIBAPS operates as a publicly funded research institute receiving grants and competitive project funding from national and international sources including Instituto de Salud Carlos III, European Union frameworks, and other research funding bodies.

clinicbarcelona.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Infrastructure, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

IDIBAPS is a public biomedical research institute that conducts translational research to bridge laboratory science and clinical patient care. It operates seven shared scientific platforms (biobank, medical statistics, MRI, cytometry, functional genomics, clinical trials, and scientific computing) that serve 101 research groups and over 2,300 professionals. The institute also delivers doctoral research training and clinical simulation education (SIMClínic), and runs knowledge and technology transfer programs linking Hospital Clínic and University of Barcelona research outputs to clinical practice.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 1,200 original articles published per year
+2 more records
Product overview1 text field

IDIBAPS operates as a unified biomedical research institute offering seven core scientific platforms as its primary infrastructure services: Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. These platforms function as integrated research support services available to affiliated research groups. Additionally, IDIBAPS provides training through SIMClínic (clinical simulation) and facilitates knowledge and technology transfer. The institute does not offer commercial software products but rather provides shared research infrastructure and services to the scientific community.

Product and service10 records
1Biobank Platform
CategoryCore Facility / Shared Research Platform
Description

Storage and management of biological samples to support biomedical research conducted by IDIBAPS research groups and collaborators.

2Medical Statistics Platform
CategoryCore Facility / Shared Research Platform
Description

Statistical support and analysis services for clinical and biomedical research data used by IDIBAPS research groups.

3Magnetic Resonance Imaging Platform
CategoryCore Facility / Shared Research Platform
Description

Advanced MRI imaging services for biomedical research applications used by IDIBAPS-affiliated research groups.

4Cytometry and Cell Separation Platform
CategoryCore Facility / Shared Research Platform
Description

Cell analysis and sorting services using flow cytometry technology for biomedical research at IDIBAPS.

5Functional Genomics Platform
CategoryCore Facility / Shared Research Platform
Description

Genomic analysis and functional study services supporting gene behavior and interaction research at IDIBAPS.

6Clinical Trials Unit
CategoryCore Facility / Shared Research Platform
Description

Infrastructure and support services for the design and execution of clinical research trials conducted at IDIBAPS.

7Scientific Computing Platform
CategoryCore Facility / Shared Research Platform
Description

High-performance computing and data analysis infrastructure for biomedical research at IDIBAPS.

8SIMClínic
CategoryTraining Program
Description

Clinical simulation training program for medical professionals and students using advanced simulation techniques.

9Doctoral Research Training
CategoryTraining Program
Description

Supervision and training of doctoral candidates across IDIBAPS research groups, producing approximately 100 doctoral theses per year.

10Knowledge and Technology Transfer Program
CategoryResearch Translation Service
Description

Programs that translate IDIBAPS research outputs into clinical and commercial applications, in collaboration with Hospital Clínic and Universitat de Barcelona.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Hospital Clínic is the primary clinical affiliate of IDIBAPS, providing the clinical environment where research is conducted and translated into patient care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The University of Barcelona is an institutional partner providing academic affiliation and research collaboration for IDIBAPS.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regional government of Catalonia provides institutional support and funding for IDIBAPS as part of the Catalan research ecosystem.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CERCA (Centres de Recerca de Catalunya) is the Catalan research centers association that includes IDIBAPS as a member institution.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Network of clinical research groups in Catalonia that IDIBAPS participates in for collaborative research initiatives.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

US-based biomedical and genomic research institute affiliated with MIT and Harvard. Comparable in its translational research model combining genomics, clinical insight, and platform infrastructure, though at a much larger operational scale.

TypeBroad incumbent
Description

Sweden's leading medical university with significant biomedical research output and hospital integration. Comparable as a publicly funded biomedical research entity with university affiliation, though much larger in size and direct clinical footprint.

TypeBroad incumbent
Description

London-based biomedical discovery research institute operating on a comparable consortium/public-funding model with hospital and university affiliations. Comparable in multi-disciplinary research group structure, though at substantially larger scale than IDIBAPS.

TypeDirect peer
Description

Barcelona-based translational cancer research institute affiliated with the Vall d'Hebron University Hospital. Comparable to IDIBAPS in its hospital-embedded research model, multi-group structure, and translational mission focused on oncology.

TypeDirect peer
Description

Barcelona-based public research institute focused on genomics and systems biology, co-located with IDIBAPS in the Barcelona biomedical cluster. Comparable in scale, CERCA membership, and core facility-driven research model.

TypeDirect peer
Description

Institute for Research in Biomedicine, a public biomedical research institute also based in Barcelona and member of the CERCA network. Highly comparable to IDIBAPS in mission (translational biomedical research), funding model (competitive grants), scale, and proximity to leading hospitals.

TypeRegional player
Description

University of Navarra's biomedical research center, comparable in size, university/hospital embedding, and translational mission, but operating in a different Spanish region.

TypeBroad incumbent
Description

Large German public research center for environmental health and biomedical research. Comparable in public funding model, multi-platform core facility structure, and translational research scope, though more disease-broad than IDIBAPS.

TypeRegional player
Description

Madrid-based public cancer research center of similar scale and funding model to IDIBAPS. Comparable in being a Spanish publicly funded biomedical research institute, though geographically distinct and more disease-focused (cancer only).

TypeDirect peer
Description

CERCA-affiliated public research institute in Barcelona focused on bioengineering and nanomedicine. Comparable in consortium structure, public funding model, and proximity within the BIST/CERCA research ecosystem.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IDIBAPS

Biomedical Research Servicesidibaps.org

IDIBAPS is a Barcelona-based biomedical research institute that runs 101 research groups across seven scientific platforms (biobank, genomics, MRI, cytometry, biostatistics, clinical trials, and scientific computing) to translate laboratory science into patient care, funded primarily through competitive public grants.

What IDIBAPS does

IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer) is a Barcelona-based biomedical research institute founded in 1996 that translates laboratory science into clinical practice. It organizes its work around 101 research groups and seven core scientific platforms: a Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. The institute serves physicians, clinical researchers, and biomedical scientists, and supervises approximately 100 doctoral theses per year alongside roughly 25 scientific seminars annually.

The institute is structured as a multi-institutional public research consortium rather than a commercial entity. It is anchored by Hospital Clínic de Barcelona (clinical environment) and Universitat de Barcelona (academic affiliation), with institutional support from Generalitat de Catalunya and membership in the CERCA network of Catalan research centers. Funding flows from competitive grants awarded by bodies such as Instituto de Salud Carlos III, the European Union framework programmes, and philanthropic organizations including the Asociación Española Contra el Cáncer, supplemented by block institutional funding. Pricing is not applicable because IDIBAPS does not commercialize products or services; outputs are scientific publications (over 1,200 original articles per year), trained researchers, clinical-trial support, and knowledge and technology transfer back to Hospital Clínic and the broader research ecosystem.

The operating footprint is concentrated at a single headquarters location at Centre Esther Koplowitz in Barcelona (C/Rosselló 149-153), where platforms and research groups are co-located with the affiliated tertiary hospital. Activity indicators — 930+ active competitive projects, recurring international collaborations, and a published 2025-2028 Strategic Plan — evidence sustained operations and incremental capability build-out (e.g., recent onboarding of high-depth multiomics instrumentation such as MACSima™). The renewed European HR Excellence in Research seal (July 2026) reinforces the institute's role as a publicly funded, translational research entity rather than a productized or revenue-generating business.

IDIBAPS firmographics

Firmographics
Name
IDIBAPS
Legal name
IDIBAPS
Website
https://idibaps.org
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
501–1,000 employees
Short description
IDIBAPS is a Barcelona-based biomedical research institute that runs 101 research groups across seven scientific platforms (biobank, genomics, MRI, cytometry, biostatistics, clinical trials, and scientific computing) to translate laboratory science into patient care, funded primarily through competitive public grants.
Ownership category
akta.pro rank

IDIBAPS industry classification

Industry
Product category
Biomedical Research Services
NAICS
Scientific Research and Development Services (5417), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
akta.pro secondary industries
Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

  • Biomedical research services
  • Translational medicine
  • Clinical trials support
  • Scientific core platforms
  • Clinical simulation training

Where IDIBAPS is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

IDIBAPS business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

  1. Competitive Research Funding: IDIBAPS operates as a publicly funded research institute receiving grants and competitive project funding from national and international sources including Instituto de Salud Carlos III, European Union frameworks, and other research funding bodies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

IDIBAPS product offering

Product offering

Core offering

IDIBAPS is a public biomedical research institute that conducts translational research to bridge laboratory science and clinical patient care. It operates seven shared scientific platforms (biobank, medical statistics, MRI, cytometry, functional genomics, clinical trials, and scientific computing) that serve 101 research groups and over 2,300 professionals. The institute also delivers doctoral research training and clinical simulation education (SIMClínic), and runs knowledge and technology transfer programs linking Hospital Clínic and University of Barcelona research outputs to clinical practice.

Product overview

IDIBAPS operates as a unified biomedical research institute offering seven core scientific platforms as its primary infrastructure services: Biobank, Medical Statistics, Magnetic Resonance Imaging, Cytometry and Cell Separation, Functional Genomics, Clinical Trials Unit, and Scientific Computing. These platforms function as integrated research support services available to affiliated research groups. Additionally, IDIBAPS provides training through SIMClínic (clinical simulation) and facilitates knowledge and technology transfer. The institute does not offer commercial software products but rather provides shared research infrastructure and services to the scientific community.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biobank Platform Storage and management of biological samples to support biomedical research conducted by IDIBAPS research groups and collaborators.
  • Medical Statistics Platform Statistical support and analysis services for clinical and biomedical research data used by IDIBAPS research groups.
  • Magnetic Resonance Imaging Platform Advanced MRI imaging services for biomedical research applications used by IDIBAPS-affiliated research groups.
  • Cytometry and Cell Separation Platform Cell analysis and sorting services using flow cytometry technology for biomedical research at IDIBAPS.
  • Functional Genomics Platform Genomic analysis and functional study services supporting gene behavior and interaction research at IDIBAPS.
  • Clinical Trials Unit Infrastructure and support services for the design and execution of clinical research trials conducted at IDIBAPS.
  • Scientific Computing Platform High-performance computing and data analysis infrastructure for biomedical research at IDIBAPS.
  • SIMClínic Clinical simulation training program for medical professionals and students using advanced simulation techniques.
  • Doctoral Research Training Supervision and training of doctoral candidates across IDIBAPS research groups, producing approximately 100 doctoral theses per year.
  • Knowledge and Technology Transfer Program Programs that translate IDIBAPS research outputs into clinical and commercial applications, in collaboration with Hospital Clínic and Universitat de Barcelona.

Quantifiable outcome

  • Over 1,200 original articles published per year
  • +2 more outcomes

Companies that use IDIBAPS

Customer profile

Segments1 record

Ideal customer profiles2 records

IDIBAPS technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

IDIBAPS partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Hospital ClíniccoreStrategic or Co-development PartnerHospital Clínic is the primary clinical affiliate of IDIBAPS, providing the clinical environment where research is conducted and translated into patient care.
  • Universitat de BarcelonacoreStrategic or Co-development PartnerThe University of Barcelona is an institutional partner providing academic affiliation and research collaboration for IDIBAPS.
  • Generalitat de CatalunyacoreStrategic or Co-development PartnerRegional government of Catalonia provides institutional support and funding for IDIBAPS as part of the Catalan research ecosystem.
  • CERCAcoreStrategic or Co-development PartnerCERCA (Centres de Recerca de Catalunya) is the Catalan research centers association that includes IDIBAPS as a member institution.
  • REGICminorStrategic or Co-development PartnerNetwork of clinical research groups in Catalonia that IDIBAPS participates in for collaborative research initiatives.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

IDIBAPS competitors and assessment

Company assessment

Broad incumbents

  • Broad Institute: US-based biomedical and genomic research institute affiliated with MIT and Harvard. Comparable in its translational research model combining genomics, clinical insight, and platform infrastructure, though at a much larger operational scale.
  • Karolinska Institutet: Sweden's leading medical university with significant biomedical research output and hospital integration. Comparable as a publicly funded biomedical research entity with university affiliation, though much larger in size and direct clinical footprint.
  • Francis Crick Institute: London-based biomedical discovery research institute operating on a comparable consortium/public-funding model with hospital and university affiliations. Comparable in multi-disciplinary research group structure, though at substantially larger scale than IDIBAPS.
  • Helmholtz Munich: Large German public research center for environmental health and biomedical research. Comparable in public funding model, multi-platform core facility structure, and translational research scope, though more disease-broad than IDIBAPS.

Direct peers

  • Vall d'Hebron Institute of Oncology (VHIO): Barcelona-based translational cancer research institute affiliated with the Vall d'Hebron University Hospital. Comparable to IDIBAPS in its hospital-embedded research model, multi-group structure, and translational mission focused on oncology.
  • Centre for Genomic Regulation (CRG): Barcelona-based public research institute focused on genomics and systems biology, co-located with IDIBAPS in the Barcelona biomedical cluster. Comparable in scale, CERCA membership, and core facility-driven research model.
  • IRB Barcelona: Institute for Research in Biomedicine, a public biomedical research institute also based in Barcelona and member of the CERCA network. Highly comparable to IDIBAPS in mission (translational biomedical research), funding model (competitive grants), scale, and proximity to leading hospitals.
  • Institute for Bioengineering of Catalonia (IBEC): CERCA-affiliated public research institute in Barcelona focused on bioengineering and nanomedicine. Comparable in consortium structure, public funding model, and proximity within the BIST/CERCA research ecosystem.

Regional players

  • CIMA (University of Navarra): University of Navarra's biomedical research center, comparable in size, university/hospital embedding, and translational mission, but operating in a different Spanish region.
  • Spanish National Cancer Research Centre (CNIO): Madrid-based public cancer research center of similar scale and funding model to IDIBAPS. Comparable in being a Spanish publicly funded biomedical research institute, though geographically distinct and more disease-focused (cancer only).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

IDIBAPS social profiles

Digital presence

IDIBAPS compliance and trust

Trust signal

Compliance1 record

IDIBAPS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IDIBAPS leadership team

Management profile

Number of profiles

IDIBAPS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IDIBAPS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IDIBAPS

What does IDIBAPS do?

IDIBAPS is a public biomedical research institute that conducts translational research to bridge laboratory science and clinical patient care. It operates seven shared scientific platforms (biobank, medical statistics, MRI, cytometry, functional genomics, clinical trials, and scientific computing) that serve 101 research groups and over 2,300 professionals. The institute also delivers doctoral research training and clinical simulation education (SIMClínic), and runs knowledge and technology transfer programs linking Hospital Clínic and University of Barcelona research outputs to clinical practice.

Is IDIBAPS a public or private company?

IDIBAPS is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was IDIBAPS founded?

IDIBAPS was founded in 1996. It employs 501 to 1,000 people.

Where is IDIBAPS based?

IDIBAPS is headquartered in Barcelona, Spain, in the Europe region.

How does IDIBAPS make money?

One revenue line is on record: competitive Research Funding.

Who are IDIBAPS's main competitors?

Broad incumbents on record are Broad Institute, Karolinska Institutet, Francis Crick Institute and Helmholtz Munich. Direct peers are Vall d'Hebron Institute of Oncology (VHIO), Centre for Genomic Regulation (CRG), IRB Barcelona and Institute for Bioengineering of Catalonia (IBEC). Regional players are CIMA (University of Navarra) and Spanish National Cancer Research Centre (CNIO).

Does IDIBAPS have an API?

No public API is recorded for IDIBAPS.

What industry is IDIBAPS in?

IDIBAPS's product category is Biomedical Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ClinicbarcelonaIDIBAPS receives an ERC-Proof-of-Concept grant for the development of a behavioural training platform for miceIDIBAPS researchers received an ERC-Proof-of-Concept grant to develop an automated behavioral training platform for mice, called Mouse Village. The platform uses implanted chips to deliver individualized training tasks, aiming to standardize electronic components for open-source distribution. Over 18 months, they will optimize the system and test it on standard cognitive tasks.ClinicbarcelonaNew Hope for Rare Neurodevelopmental Disorders: Targeting Shared Synaptic MechanismsThe HypoGluTx project, coordinated by IDIBAPS and funded with over 1 million € by the European Rare Diseases Research Alliance (ERDERA), has launched to treat rare neurodevelopmental disorders by targeting shared synaptic mechanisms. The multinational consortium aims to repurpose existing drugs for conditions linked to mutations in genes such as GRIN2B and SHANK3, involving academic partners from Spain, Portugal, the Netherlands, and France. This initiative seeks to accelerate therapeutic development by studying these disorders side-by-side rather than individually.ClinicbarcelonaHospital Clínic-IDIBAPS and Immuneel Therapeutics announce a strategic collaboration to improveHospitals and research institutions in Spain and India are collaborating to develop and commercialize CAR T cell therapies, specifically the ARI-0001 product, which shows promise in treating hematological disorders. The partnership aims to make these advanced therapies more affordable and accessible in India while maintaining high safety and efficacy standards. The collaboration builds on prior clinical success and regulatory review of ARI-0001 in Spain.Leadership NewsBuni Commends Global Scientists For Kidney, Other Diseases Research In YobeGovernor Mai Mala Buni of Yobe State commended the Biomedical Research and Training Centre (BioRTC) for its research into kidney diseases and hosted its Computational Neuroscience Summer School. The initiative, led by Professor Mahmud Bukar Maina, involves international collaboration with institutions such as the University of Sussex in the UK and IDIBAPS in Spain to build scientific capacity in Africa.NaciodigitalTres metges de Vic lideren un estudi que marca una abans i un després en la prevenció de l'artritis reumatoideA clinical trial led by researchers from IDIBAPS-Hospital Clínic de Barcelona and Hospital Universitari de Vic has demonstrated that the drug abatacept is significantly more effective than hydroxychloroquine in preventing rheumatoid arthritis in patients with palindromic rheumatism. Published in Nature Medicine, the study found that only 20% of patients treated with abatacept developed rheumatoid arthritis over two years, compared to 50% in the control group. This finding suggests a potential paradigm shift in early intervention strategies for this autoimmune condition.ClinicbarcelonaSusana Puig - Melanoma: imagen, genética e inmunologíaSusana Puig, a group leader at IDIBAPS, outlines the research focus of her multidisciplinary team on melanoma and non-melanoma skin cancers. The group utilizes translational research combining clinical studies with molecular analysis and artificial intelligence to improve prevention, early diagnosis, and personalized treatment. Previous work has enhanced early detection rates and identified key susceptibility genes and prognostic markers for melanoma.PR NewswireIDIBAPS Researchers Discover Genetic Drivers of Clonal Evolution in Leukemia Using Single-Cell DNA Sequencing from Mission BioResearchers at IDIBAPS in Barcelona, Spain published findings in Nature Medicine using Mission Bio's Tapestri® single-cell DNA sequencing platform to identify genetic drivers of Richter's syndrome, the deadly progression from chronic lymphocytic leukemia to aggressive B cell lymphoma. The study detected rare subclones in approximately five cells years before disease expansion, demonstrating that treatment drives selection for these subclones—a finding impossible with traditional bulk sequencing methods. The results suggest targeting these dormant subclones therapeutically could prevent CLL patients from developing the aggressive lymphoma, which has a median survival of one year or less.PR NewswireSOPHiA GENETICS Launches New Solution to Advance Chronic Lymphocytic Leukemia Care, in Collaboration with IDIBAPSSOPHiA GENETICS, in collaboration with IDIBAPS and Diagnóstica Longwood, announced at the European Hematology Association Congress in Vienna the launch of a new Chronic Lymphocytic Leukemia solution that unifies guideline recommendations into a single application to improve CLL characterization and research in Iberia. The solution, which allows hematopathologists to access guidelines for mutational status and identify 23 CLL-specific genes, has already been deployed in routine practice in Spain with expansion planned across Latin America. CLL accounts for 25-30% of all leukemia cases in Western countries and affects more than 100,000 people globally each year.ClinicbarcelonaProf. Oscar Marín talks at the IDIBAPS Seminar about the molecular basis of schizophrenia | HosProf. Oscar Marín presented at an IDIBAPS seminar on October 22, 2012, discussing his research on Erbb4 signaling and cortical interneurons. He argued that disruption of inhibitory circuits may underlie schizophrenia, autism, and intellectual disabilities, with his work potentially informing better therapies.